|
14 Sep 2021 |
AbbVie and REGENXBIO Announce Eye Care Collaboration
|
|
11 Sep 2021 |
Flamingo Therapeutics Expands Alliance with Ionis Pharmaceuticals to Develop RNA-targeted Therapies for Oncology
|
|
11 Sep 2021 |
Boehringer Ingelheim and Twist Bioscience Enter Therapeutic Antibody Discovery Collaboration September 9, 2021
|
|
10 Sep 2021 |
ADARx Raises $75 Million to Advance Growing Pipeline
|
|
09 Sep 2021 |
PAQ Therapeutics Announces Collaboration with Insilico Medicine to Develop Novel Therapies through Autophagy-Dependent Degradation
|
|
09 Sep 2021 |
Lycia Therapeutics Announces $70 Million Series B Financing Led by Redmile Group with Participation from Founding Investor Versant Ventures
|
|
09 Sep 2021 |
ProQR Announces Axiomer® RNA Editing Licensing and Research Collaboration with Lilly
|
|
09 Sep 2021 |
Sanofi to acquire Kadmon to further strengthen growth of transplant business
|
|
07 Sep 2021 |
NeuExcell Therapeutics and Spark Therapeutics Announce Research Collaboration Agreement to Develop a Novel Gene Therapy for Huntington's Disease
|
|
07 Sep 2021 |
Moderna and the Institute for Life Changing Medicines Announce a New Collaboration to Develop an mRNA Therapeutic for Ultra-Rare Disease, Crigler-Najjar Syndrome Type 1
|
|
07 Sep 2021 |
National Cancer Institute (NCI) Awards Isoprene Pharmaceuticals, Inc. a Two-Year $2 Million Small Business Innovation Research (SBIR) Grant
|
|
03 Sep 2021 |
Evotec announces Bristol Myers Squibb opt-in of EVT8683 as the first programme from iPSC-based neurodegeneration collaboration
|
|
02 Sep 2021 |
Brickell Biotech Acquires Exclusive Rights to Phase 1-Ready DYRK1A Inhibitor Program and Novel Platform Targeting Autoimmune and Inflammatory Diseases
|
|
31 Aug 2021 |
Adaptive Phage Therapeutics Announces Licensing Agreement with the Walter Reed Army Institute of Research
|
|
30 Aug 2021 |
Bone Therapeutics announces topline results from Phase III knee osteoarthritis study with its enhanced viscosupplement JTA-004
|
|
26 Aug 2021 |
NovaRock Biotherapeutics Announces Exclusive License Agreement and Strategic Partnership with Flame BioSciences
|
|
25 Aug 2021 |
Eagle Pharmaceuticals Announces Worldwide Licensing Agreement with Combioxin SA for Phase 2b/3, Novel First-in-Class Antitoxin Agent CAL02 in Development for Combination Use with Antibiotics for the Treatment of Severe Pneumonia
|
|
24 Aug 2021 |
Shape Therapeutics enters into a strategic research collaboration with Roche to advance breakthrough AAV-based RNA editing technology for neuroscience and rare disease indications
|
|
24 Aug 2021 |
AdAlta and Carina Biotech to develop next-generation CAR-T cancer therapeutics
|
|
24 Aug 2021 |
Abveris and Abilita Bio Announce a Discovery Collaboration to Develop Therapeutics for Challenging Membrane Protein Targets
|
|
24 Aug 2021 |
Vertex and Arbor Biotechnologies Establish New Partnership to Develop Novel ex vivo Engineered Cell Therapies
|
|
23 Aug 2021 |
Pfizer to Acquire Trillium Therapeutics Inc.
|
|
19 Aug 2021 |
Jnana Therapeutics closes $50 million Series B financing to advance lead PKU program and small molecule pipeline based on next gen chemoproteomic platform
|
|
19 Aug 2021 |
Immunitas Therapeutics Completes $58 Million Series B Financing to Advance Pipeline into the Clinic and Expand Single Cell Analysis Drug Development Platform for Immuno-Oncology and Other Diseases
|
|
19 Aug 2021 |
Vigil Neuroscience Completes $90 million Series B Financing to Advance a Pipeline of Microglia-targeted Medicines to Treat Rare and Common Neurodegenerative Diseases
|
